Plasma orexin-A is lower in patients with narcolepsy

S. Higuchi, A. Usui, M. Murasaki, S. Matsushita, N. Nishioka, A. Yoshino, T. Matsui, H. Muraoka, Y. Ishizuka, Shigenobu Kanba, T. Sakurai

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Recently identified hypothalamic peptides called orexins (or hypocretins) have been implicated in the sleep-wake cycle and in sleep disorder narcolepsy. Neuropathological studies have shown that in patients with narcolepsy, global reduction in the expression of orexins occurs due to the loss of orexin neurons in the hypothalamus. Cerebrospinal fluid analysis has confirmed a reduced or undetectable level of orexin-A in most narcolepsy patients. In this study, measurement of plasma orexin showed significantly lower concentrations in patients with narcolepsy than in age- and gender-matched normal controls. These data suggest that low levels of orexin-A in plasma could serve as a biological marker for narcolepsy.

Original languageEnglish
Pages (from-to)61-64
Number of pages4
JournalNeuroscience Letters
Volume318
Issue number2
DOIs
Publication statusPublished - Jan 25 2002

Fingerprint

Narcolepsy
Circadian Rhythm Sleep Disorders
Hypothalamus
Cerebrospinal Fluid
Sleep
Biomarkers
Orexins
Neurons
Peptides

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Higuchi, S., Usui, A., Murasaki, M., Matsushita, S., Nishioka, N., Yoshino, A., ... Sakurai, T. (2002). Plasma orexin-A is lower in patients with narcolepsy. Neuroscience Letters, 318(2), 61-64. https://doi.org/10.1016/S0304-3940(01)02476-4

Plasma orexin-A is lower in patients with narcolepsy. / Higuchi, S.; Usui, A.; Murasaki, M.; Matsushita, S.; Nishioka, N.; Yoshino, A.; Matsui, T.; Muraoka, H.; Ishizuka, Y.; Kanba, Shigenobu; Sakurai, T.

In: Neuroscience Letters, Vol. 318, No. 2, 25.01.2002, p. 61-64.

Research output: Contribution to journalArticle

Higuchi, S, Usui, A, Murasaki, M, Matsushita, S, Nishioka, N, Yoshino, A, Matsui, T, Muraoka, H, Ishizuka, Y, Kanba, S & Sakurai, T 2002, 'Plasma orexin-A is lower in patients with narcolepsy', Neuroscience Letters, vol. 318, no. 2, pp. 61-64. https://doi.org/10.1016/S0304-3940(01)02476-4
Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A et al. Plasma orexin-A is lower in patients with narcolepsy. Neuroscience Letters. 2002 Jan 25;318(2):61-64. https://doi.org/10.1016/S0304-3940(01)02476-4
Higuchi, S. ; Usui, A. ; Murasaki, M. ; Matsushita, S. ; Nishioka, N. ; Yoshino, A. ; Matsui, T. ; Muraoka, H. ; Ishizuka, Y. ; Kanba, Shigenobu ; Sakurai, T. / Plasma orexin-A is lower in patients with narcolepsy. In: Neuroscience Letters. 2002 ; Vol. 318, No. 2. pp. 61-64.
@article{0004403593d5466e97192bda1e73769e,
title = "Plasma orexin-A is lower in patients with narcolepsy",
abstract = "Recently identified hypothalamic peptides called orexins (or hypocretins) have been implicated in the sleep-wake cycle and in sleep disorder narcolepsy. Neuropathological studies have shown that in patients with narcolepsy, global reduction in the expression of orexins occurs due to the loss of orexin neurons in the hypothalamus. Cerebrospinal fluid analysis has confirmed a reduced or undetectable level of orexin-A in most narcolepsy patients. In this study, measurement of plasma orexin showed significantly lower concentrations in patients with narcolepsy than in age- and gender-matched normal controls. These data suggest that low levels of orexin-A in plasma could serve as a biological marker for narcolepsy.",
author = "S. Higuchi and A. Usui and M. Murasaki and S. Matsushita and N. Nishioka and A. Yoshino and T. Matsui and H. Muraoka and Y. Ishizuka and Shigenobu Kanba and T. Sakurai",
year = "2002",
month = "1",
day = "25",
doi = "10.1016/S0304-3940(01)02476-4",
language = "English",
volume = "318",
pages = "61--64",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Plasma orexin-A is lower in patients with narcolepsy

AU - Higuchi, S.

AU - Usui, A.

AU - Murasaki, M.

AU - Matsushita, S.

AU - Nishioka, N.

AU - Yoshino, A.

AU - Matsui, T.

AU - Muraoka, H.

AU - Ishizuka, Y.

AU - Kanba, Shigenobu

AU - Sakurai, T.

PY - 2002/1/25

Y1 - 2002/1/25

N2 - Recently identified hypothalamic peptides called orexins (or hypocretins) have been implicated in the sleep-wake cycle and in sleep disorder narcolepsy. Neuropathological studies have shown that in patients with narcolepsy, global reduction in the expression of orexins occurs due to the loss of orexin neurons in the hypothalamus. Cerebrospinal fluid analysis has confirmed a reduced or undetectable level of orexin-A in most narcolepsy patients. In this study, measurement of plasma orexin showed significantly lower concentrations in patients with narcolepsy than in age- and gender-matched normal controls. These data suggest that low levels of orexin-A in plasma could serve as a biological marker for narcolepsy.

AB - Recently identified hypothalamic peptides called orexins (or hypocretins) have been implicated in the sleep-wake cycle and in sleep disorder narcolepsy. Neuropathological studies have shown that in patients with narcolepsy, global reduction in the expression of orexins occurs due to the loss of orexin neurons in the hypothalamus. Cerebrospinal fluid analysis has confirmed a reduced or undetectable level of orexin-A in most narcolepsy patients. In this study, measurement of plasma orexin showed significantly lower concentrations in patients with narcolepsy than in age- and gender-matched normal controls. These data suggest that low levels of orexin-A in plasma could serve as a biological marker for narcolepsy.

UR - http://www.scopus.com/inward/record.url?scp=0037169230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037169230&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(01)02476-4

DO - 10.1016/S0304-3940(01)02476-4

M3 - Article

C2 - 11796186

AN - SCOPUS:0037169230

VL - 318

SP - 61

EP - 64

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -